Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

Item

http://www.wikidata.org/entity/Q36507978

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

@ast

Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

@en

type

Item

label

Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

@ast

Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

@en

prefLabel

Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

@ast

Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

@en

P1476

Dendritic cell vaccination in glioblastoma after fluorescence-guided resection

@en

P2093

Ascension Lopez-Diaz de Cerio

http://www.w3.org/2001/XMLSchema#string

Helena Villanueva

http://www.w3.org/2001/XMLSchema#string

Jaime Espinos

http://www.w3.org/2001/XMLSchema#string

Maurizio Bendandi

http://www.w3.org/2001/XMLSchema#string

Miguel Angel Idoate

http://www.w3.org/2001/XMLSchema#string

Ricardo Diez Valle

http://www.w3.org/2001/XMLSchema#string

Sonia Tejada

http://www.w3.org/2001/XMLSchema#string

Susana Inoges

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cell vaccines for brain tumors

The 2007 WHO classification of tumours of the central nervous system

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.

Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

P304

142-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V3.I11.142

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Enrique J. Andreu

Jaime Gállego Pérez-Larraya

Fernando Pastor

Javier Aristu

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234071372

http://www.w3.org/2001/XMLSchema#string

P698

23293753

http://www.w3.org/2001/XMLSchema#string

P932

3536842

http://www.w3.org/2001/XMLSchema#string